 |
6 Diseases |  |
1 Trial |
|
1 Trial |  |
2 News |  |
- ||| LGT209 / Novartis
New P1 trial: Safety, Tolerability, PK and PD of LGT209 in Healthy Volunteers and Patients With Hypercholesterolemia (clinicaltrials.gov) - Nov 6, 2013
P1, N=74, Completed, Sponsor: Novartis Pharmaceuticals
- | LGT209 / Novartis
New P1 trial: Safety, Pharmacokinetics and Pharmacodynamics of LGT209 in Healthy Volunteers With Elevated Cholesterol and in Hypercholesterolemic Patients Treated With Statins (clinicaltrials.gov) - May 20, 2013
P1, N=25, Completed, Sponsor: Novartis Pharmaceuticals